Ken Griffin acquired 24.1 Thousand Rocket Pharmaceuticals shares worth $571 Thousand. That's 0.00% of their equity portfolio (3254th largest holding). The first Rocket Pharmaceuticals trade was made in Q1 2018. Since then Ken Griffin bought shares 34 more times and sold shares on 21 occasions. The stake costed the investor $451 Thousand, netting the investor a gain of 27% so far.